Tom Otis, PhD, is the chief scientific officer at Lario Therapeutics and a professor of neuroscience at University College London, where he also serves as the chief scientific officer at the Sainsbury Wellcome Centre for Neural Circuits and Behaviour. His experience spans more than 30 years in both academia and industry. Prior to UCL/SWC, he led a team of 45 scientists conducting early-stage drug development in neurodevelopmental disorders and psychiatry at Roche Pharma R&D in Basel. Before Roche, he served as the Edith Agnes Plumb Chair of the department of neurobiology at the University of California, Los Angeles. Dr. Otis received his BS and MSc degrees in biological sciences in 1988 and his PhD in neuroscience in 1993 from Stanford University. His research has focused on cellular and circuit function of the cerebellum and hippocampus, motor systems function and motor learning, and preclinical models of epilepsies, spinocerebellar ataxia and amyotrophic lateral sclerosis.